NDC 63323-875

Foscarnet

Foscarnet Sodium

Foscarnet is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Foscarnet Sodium.

Product ID63323-875_773fcafd-38ca-4aeb-9ecd-e7d436560ddb
NDC63323-875
Product TypeHuman Prescription Drug
Proprietary NameFoscarnet
Generic NameFoscarnet Sodium
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-01-29
Marketing CategoryANDA / ANDA
Application NumberANDA212483
Labeler NameFresenius Kabi USA, LLC
Substance NameFOSCARNET SODIUM
Active Ingredient Strength24 mg/mL
Pharm ClassesDNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [EXT],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC],Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63323-875-50

1 BOTTLE in 1 CARTON (63323-875-50) > 250 mL in 1 BOTTLE
Marketing Start Date2021-01-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Foscarnet" or generic name "Foscarnet Sodium"

NDCBrand NameGeneric Name
63323-875Foscarnetfoscarnet sodium
25021-189Foscarnet SodiumFoscarnet Sodium
68083-389Foscarnet SodiumFoscarnet Sodium
76310-024Foscavirfoscarnet sodium

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.